Benefits of new retinal implant clear to see, but experts remain divided
This article was originally published in Clinica
Executive Summary
Results from a study of an experimental retinal transplant have suggested that the technique could improve the vision of patients with chronic eye disease. The phase II trial was conducted in 10 patients with retinitis pigmentosa (RP) or age-related macular degeneration (AMD) with 20/200 vision or worse. A person with visual acuity of 20/200 or below is considered legally blind in the US. 20/20 vision is considered nominal performance.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.